News

Hidradenitis suppurativa (HS), a chronic skin condition characterized by painful abscesses and scarring, often proves resistant to conventional treatments. In...

The U.S. Food and Drug Administration (FDA) has accepted the resubmission of a supplemental biologics license application (sBLA) for Dupixent...

A recent analysis from the SUNSHINE (NCT03713619) and SUNRISE (NCT03713632) phase 3 trials has revealed promising results for secukinumab in...

Air pollution, a byproduct of industrialization, is widely recognized for its negative impact on respiratory health. However, a recent study...

Researchers at the University of Massachusetts Amherst have developed a groundbreaking, sprayable drug delivery system for treating psoriasis that could...

New York, NY – November 1, 2024 – In honor of National Healthy Skin Month this November, the American Skin...

Stockholm, Sweden – SciBase Holding AB (STO: SCIB), a leader in artificial intelligence-driven solutions for skin diagnostics, has announced promising...

Researchers at the University of Copenhagen have developed an innovative patch that could significantly improve the treatment experience for psoriasis...

Health Union, a leader in patient-centered market research, has released its 2024 findings from the "In America" and "Patient Experience"...

Revolutionary platform receives FDA clearance, offering real-time insights for dermatologists. Enspectra Health, a pioneering health technology company, has made a...